Transoceanic Travelers Need to Correct Insulin Timing
|
By HospiMedica International staff writers Posted on 09 Jun 2016 |

Image: New research suggests air travel across multiple time zones may require adjustment of diabetes medications (Photo courtesy of the University of Texas Medical Branch).
Air travel passengers crossing multiple time zones may have to adjust their insulin dose to protect themselves against episodes of hypoglycemia, according to a new study.
Researchers at the University of Texas Medical Branch (UTMB, Galveston, USA) conducted a review of PUBMED and MEDLINE databases for articles that discussed air travel and diabetes. In all, 99 peer-reviewed articles and two diabetic nursing guidelines were identified. The researchers found that about 2% of airline related diversions due to medical emergencies are due to diabetes complications, and that 10% of diabetics who travel will have a problem.
The researchers also made several recommendations. First, they stated that for short/rapid-acting insulin, no dose adjustment was needed. During eastward travel, intermediate/long-acting insulin should be reduced in dose proportional to hours lost. During westward travel, correction scale insulin with rapid acting insulin can be used, or the dose to be administered during travel can be given as divided doses to span the longer travel day.
They also discouraged the use of pre-mixed insulin, due to difficulty in titrating effects, and added that insulin pumps could be used per usual basal bolus dosing; however, cabin depressurization may lead to unintended bolus dosing, increasing the risk of hypoglycemia. The study was presented at the annual meeting of the American Association of Clinical Endocrinologists, held during May 2016 in Orlando (FL, USA).
“When people travel and are not attentive to their insulin intake they can either overdose or underdose their insulin. It can happen because they are taking their regular amount of insulin but not eating enough, or they are taking their insulin too early, usually if a person is traveling east across multiple time zones,” said study presenter Rahul Suresh, MD. “When traveling west, there may be gaps in diabetic complications causing hyperglycemia, which is important among patients diagnosed with type 1 diabetes.”
“When flying from the U.S. to Europe, for example, a person would be in danger of taking too much basal insulin due to a 6-hour time change, so they need to adjust their daily dose in the U.S. to 75% of normal,” added Dr. Suresh. “Therefore, when they take the full dose in Europe they haven't taken too much insulin. Similarly, when going west, patients with diabetes and on insulin may have to increase their dosages because the day can be longer.”
Related Links:
University of Texas Medical Branch
Researchers at the University of Texas Medical Branch (UTMB, Galveston, USA) conducted a review of PUBMED and MEDLINE databases for articles that discussed air travel and diabetes. In all, 99 peer-reviewed articles and two diabetic nursing guidelines were identified. The researchers found that about 2% of airline related diversions due to medical emergencies are due to diabetes complications, and that 10% of diabetics who travel will have a problem.
The researchers also made several recommendations. First, they stated that for short/rapid-acting insulin, no dose adjustment was needed. During eastward travel, intermediate/long-acting insulin should be reduced in dose proportional to hours lost. During westward travel, correction scale insulin with rapid acting insulin can be used, or the dose to be administered during travel can be given as divided doses to span the longer travel day.
They also discouraged the use of pre-mixed insulin, due to difficulty in titrating effects, and added that insulin pumps could be used per usual basal bolus dosing; however, cabin depressurization may lead to unintended bolus dosing, increasing the risk of hypoglycemia. The study was presented at the annual meeting of the American Association of Clinical Endocrinologists, held during May 2016 in Orlando (FL, USA).
“When people travel and are not attentive to their insulin intake they can either overdose or underdose their insulin. It can happen because they are taking their regular amount of insulin but not eating enough, or they are taking their insulin too early, usually if a person is traveling east across multiple time zones,” said study presenter Rahul Suresh, MD. “When traveling west, there may be gaps in diabetic complications causing hyperglycemia, which is important among patients diagnosed with type 1 diabetes.”
“When flying from the U.S. to Europe, for example, a person would be in danger of taking too much basal insulin due to a 6-hour time change, so they need to adjust their daily dose in the U.S. to 75% of normal,” added Dr. Suresh. “Therefore, when they take the full dose in Europe they haven't taken too much insulin. Similarly, when going west, patients with diabetes and on insulin may have to increase their dosages because the day can be longer.”
Related Links:
University of Texas Medical Branch
Latest Critical Care News
- Pulse Oximeter Index Offers Non-Invasive Guides for Fluid Therapy
- Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
- 'Universal' Kidney to Match Any Blood Type
- Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries

- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
Channels
Surgical Techniques
view channel
Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide, affecting nearly 200 million people, a figure expected to rise to 280 million by 2040. Current treatment involves doctors... Read more
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







